Skip to main content
NCBI home page
Molecular and Cellular Biology logoLink to Molecular and Cellular Biology
. 1993 Dec;13(12):7447–7456. doi: 10.1128/mcb.13.12.7447

Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo.

H Matsushima 1, E Bogenmann 1
PMCID: PMC364816  PMID: 8246962

Abstract

The human trkA cDNA was transfected into a malignant human neuroblastoma (NB) cell line (HTLA230) to investigate its role in NB growth and differentiation. This cell line lacks expression of both endogenous trkA and gp75NGFR genes. Transfectants expressing the trkA mRNA and surface-bound receptors transcriptionally activate immediate-early genes (c-fos, c-jun, and jun-B) following nerve growth factor (NGF) stimulation. NGF treatment induces growth arrest as well as down-regulation of the amplified N-myc oncogene. Genes selectively expressed in mature neurons (SCG-10, ret proto-oncogene, GAP-43, etc.) are transcriptionally activated, and neurite outgrowth further demonstrates differentiation of transfectants following NGF stimulation. trkA-expressing NB cells remain tumorigenic in nude mice; however, subcutaneous treatment of tumor-bearing mice with NGF induces Schwannian and neuronal cell differentiation similar to the induction seen in human ganglioneuroblastomas. Thus, trkA expression in HTLA230 cells is sufficient to generate a functional NGF receptor complex that leads to growth-arrested and differentiated NB cells in vitro and in vivo in the presence of NGF. Hence, NGF may play a crucial role in NB cell differentiation and regression in vivo.

Full text

PDF
7447

Images in this article

7448Image
on p.7448
7449Image
on p.7449
7450Image
on p.7450
7451Image
on p.7451
7451Image
on p.7451
7452Image
on p.7452
7453Image
on p.7453

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams J. C., Watt F. M. Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature. 1989 Jul 27;340(6231):307–309. doi: 10.1038/340307a0. [DOI] [PubMed] [Google Scholar]
  2. Azar C. G., Scavarda N. J., Reynolds C. P., Brodeur G. M. Multiple defects of the nerve growth factor receptor in human neuroblastomas. Cell Growth Differ. 1990 Sep;1(9):421–428. [PubMed] [Google Scholar]
  3. Birren S. J., Anderson D. J. A v-myc-immortalized sympathoadrenal progenitor cell line in which neuronal differentiation is initiated by FGF but not NGF. Neuron. 1990 Feb;4(2):189–201. doi: 10.1016/0896-6273(90)90094-v. [DOI] [PubMed] [Google Scholar]
  4. Bothwell M. Tissue localization of nerve growth factor and nerve growth factor receptors. Curr Top Microbiol Immunol. 1991;165:55–70. doi: 10.1007/978-3-642-75747-1_4. [DOI] [PubMed] [Google Scholar]
  5. Chao M. V. Neurotrophin receptors: a window into neuronal differentiation. Neuron. 1992 Oct;9(4):583–593. doi: 10.1016/0896-6273(92)90023-7. [DOI] [PubMed] [Google Scholar]
  6. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  7. Cowan N. J., Dobner P. R., Fuchs E. V., Cleveland D. W. Expression of human alpha-tubulin genes: interspecies conservation of 3' untranslated regions. Mol Cell Biol. 1983 Oct;3(10):1738–1745. doi: 10.1128/mcb.3.10.1738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Curran T., Peters G., Van Beveren C., Teich N. M., Verma I. M. FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J Virol. 1982 Nov;44(2):674–682. doi: 10.1128/jvi.44.2.674-682.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dammerman M., Yen S. H., Shafit-Zagardo B. Sequence of a human MAP-2 region sharing epitopes with Alzheimer neurofibrillary tangles. J Neurosci Res. 1989 Dec;24(4):487–495. doi: 10.1002/jnr.490240405. [DOI] [PubMed] [Google Scholar]
  10. Eager K. B. Molecular characterization of human trk proto-oncogene product monoclonal antibodies. Oncogene. 1991 May;6(5):819–824. [PubMed] [Google Scholar]
  11. Giard D. J., Aaronson S. A., Todaro G. J., Arnstein P., Kersey J. H., Dosik H., Parks W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973 Nov;51(5):1417–1423. doi: 10.1093/jnci/51.5.1417. [DOI] [PubMed] [Google Scholar]
  12. Grady-Leopardi E. F., Schwab M., Ablin A. R., Rosenau W. Detection of N-myc oncogene expression in human neuroblastoma by in situ hybridization and blot analysis: relationship to clinical outcome. Cancer Res. 1986 Jun;46(6):3196–3199. [PubMed] [Google Scholar]
  13. Greenberg M. E., Greene L. A., Ziff E. B. Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells. J Biol Chem. 1985 Nov 15;260(26):14101–14110. [PubMed] [Google Scholar]
  14. Hattori K., Angel P., Le Beau M. M., Karin M. Structure and chromosomal localization of the functional intronless human JUN protooncogene. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9148–9152. doi: 10.1073/pnas.85.23.9148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hempstead B. L., Martin-Zanca D., Kaplan D. R., Parada L. F., Chao M. V. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature. 1991 Apr 25;350(6320):678–683. doi: 10.1038/350678a0. [DOI] [PubMed] [Google Scholar]
  16. Hempstead B. L., Schleifer L. S., Chao M. V. Expression of functional nerve growth factor receptors after gene transfer. Science. 1989 Jan 20;243(4889):373–375. doi: 10.1126/science.2536190. [DOI] [PubMed] [Google Scholar]
  17. Ibáez C. F., Ebendal T., Barbany G., Murray-Rust J., Blundell T. L., Persson H. Disruption of the low affinity receptor-binding site in NGF allows neuronal survival and differentiation by binding to the trk gene product. Cell. 1992 Apr 17;69(2):329–341. doi: 10.1016/0092-8674(92)90413-7. [DOI] [PubMed] [Google Scholar]
  18. Ignatius M. J., Chandler C. R., Shooter E. M. Nerve growth factor-treated, neurite-bearing PC12 cells continue to synthesize DNA. J Neurosci. 1985 Feb;5(2):343–351. doi: 10.1523/JNEUROSCI.05-02-00343.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ikenaka K., Nakahira K., Takayama C., Wada K., Hatanaka H., Mikoshiba K. Nerve growth factor rapidly induces expression of the 68-kDa neurofilament gene by posttranscriptional modification in PC12h-R cells. J Biol Chem. 1990 Nov 15;265(32):19782–19785. [PubMed] [Google Scholar]
  20. Ip N. Y., Stitt T. N., Tapley P., Klein R., Glass D. J., Fandl J., Greene L. A., Barbacid M., Yancopoulos G. D. Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells. Neuron. 1993 Feb;10(2):137–149. doi: 10.1016/0896-6273(93)90306-c. [DOI] [PubMed] [Google Scholar]
  21. Ito E., Nomura N., Narayanan R. Transcriptional regulation of early growth response genes in FOS-expressing PC-12 cells. Cell Regul. 1990 Mar;1(4):347–357. doi: 10.1091/mbc.1.4.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jessell T. M. Adhesion molecules and the hierarchy of neural development. Neuron. 1988 Mar;1(1):3–13. doi: 10.1016/0896-6273(88)90204-8. [DOI] [PubMed] [Google Scholar]
  23. Jing S., Tapley P., Barbacid M. Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron. 1992 Dec;9(6):1067–1079. doi: 10.1016/0896-6273(92)90066-m. [DOI] [PubMed] [Google Scholar]
  24. Johnson D., Lanahan A., Buck C. R., Sehgal A., Morgan C., Mercer E., Bothwell M., Chao M. Expression and structure of the human NGF receptor. Cell. 1986 Nov 21;47(4):545–554. doi: 10.1016/0092-8674(86)90619-7. [DOI] [PubMed] [Google Scholar]
  25. Karns L. R., Ng S. C., Freeman J. A., Fishman M. C. Cloning of complementary DNA for GAP-43, a neuronal growth-related protein. Science. 1987 May 1;236(4801):597–600. doi: 10.1126/science.2437653. [DOI] [PubMed] [Google Scholar]
  26. Klein R., Jing S. Q., Nanduri V., O'Rourke E., Barbacid M. The trk proto-oncogene encodes a receptor for nerve growth factor. Cell. 1991 Apr 5;65(1):189–197. doi: 10.1016/0092-8674(91)90419-y. [DOI] [PubMed] [Google Scholar]
  27. Kuwano R., Usui H., Maeda T., Araki K., Yamakuni T., Kurihara T., Takahashi Y. Tissue distribution of rat S-100 alpha and beta subunit mRNAs. Brain Res. 1987 Apr;388(1):79–82. [PubMed] [Google Scholar]
  28. Kuwano R., Usui H., Maeda T., Fukui T., Yamanari N., Ohtsuka E., Ikehara M., Takahashi Y. Molecular cloning and the complete nucleotide sequence of cDNA to mRNA for S-100 protein of rat brain. Nucleic Acids Res. 1984 Oct 11;12(19):7455–7465. doi: 10.1093/nar/12.19.7455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lee K. F., Li E., Huber L. J., Landis S. C., Sharpe A. H., Chao M. V., Jaenisch R. Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell. 1992 May 29;69(5):737–749. doi: 10.1016/0092-8674(92)90286-l. [DOI] [PubMed] [Google Scholar]
  30. Leonard D. G., Ziff E. B., Greene L. A. Identification and characterization of mRNAs regulated by nerve growth factor in PC12 cells. Mol Cell Biol. 1987 Sep;7(9):3156–3167. doi: 10.1128/mcb.7.9.3156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Loeb D. M., Greene L. A. Transfection with trk restores "slow" NGF binding, efficient NGF uptake, and multiple NGF responses to NGF-nonresponsive PC12 cell mutants. J Neurosci. 1993 Jul;13(7):2919–2929. doi: 10.1523/JNEUROSCI.13-07-02919.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Loeb D. M., Maragos J., Martin-Zanca D., Chao M. V., Parada L. F., Greene L. A. The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines. Cell. 1991 Sep 6;66(5):961–966. doi: 10.1016/0092-8674(91)90441-z. [DOI] [PubMed] [Google Scholar]
  33. MacLeod A. R. Expression of the mRNA coding for glyceraldehyde-3-phosphate dehydrogenase. Eur J Biochem. 1981 Oct;119(2):353–358. doi: 10.1111/j.1432-1033.1981.tb05615.x. [DOI] [PubMed] [Google Scholar]
  34. Marchetti D., Perez-Polo J. R. Nerve growth factor receptors in human neuroblastoma cells. J Neurochem. 1987 Aug;49(2):475–486. doi: 10.1111/j.1471-4159.1987.tb02889.x. [DOI] [PubMed] [Google Scholar]
  35. Martin-Zanca D., Oskam R., Mitra G., Copeland T., Barbacid M. Molecular and biochemical characterization of the human trk proto-oncogene. Mol Cell Biol. 1989 Jan;9(1):24–33. doi: 10.1128/mcb.9.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Matsushima H., Bogenmann E. Bi-modal differentiation pattern in a new human neuroblastoma cell line in vitro. Int J Cancer. 1992 May 8;51(2):250–258. doi: 10.1002/ijc.2910510214. [DOI] [PubMed] [Google Scholar]
  37. Matsushima H., Bogenmann E. Modulation of neuroblastoma cell differentiation by the extracellular matrix. Int J Cancer. 1992 Jul 9;51(5):727–732. doi: 10.1002/ijc.2910510511. [DOI] [PubMed] [Google Scholar]
  38. Matsushima H., Bogenmann E. Nerve growth factor (NGF) induces neuronal differentiation in neuroblastoma cells transfected with the NGF receptor cDNA. Mol Cell Biol. 1990 Sep;10(9):5015–5020. doi: 10.1128/mcb.10.9.5015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Meakin S. O., Shooter E. M. Molecular investigations on the high-affinity nerve growth factor receptor. Neuron. 1991 Jan;6(1):153–163. doi: 10.1016/0896-6273(91)90130-r. [DOI] [PubMed] [Google Scholar]
  40. Nakagawara A., Arima-Nakagawara M., Scavarda N. J., Azar C. G., Cantor A. B., Brodeur G. M. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med. 1993 Mar 25;328(12):847–854. doi: 10.1056/NEJM199303253281205. [DOI] [PubMed] [Google Scholar]
  41. Nomura N., Ide M., Sasamoto S., Matsui M., Date T., Ishizaki R. Isolation of human cDNA clones of jun-related genes, jun-B and jun-D. Nucleic Acids Res. 1990 May 25;18(10):3047–3048. doi: 10.1093/nar/18.10.3047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Pleasure S. J., Reddy U. R., Venkatakrishnan G., Roy A. K., Chen J., Ross A. H., Trojanowski J. Q., Pleasure D. E., Lee V. M. Introduction of nerve growth factor (NGF) receptors into a medulloblastoma cell line results in expression of high- and low-affinity NGF receptors but not NGF-mediated differentiation. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8496–8500. doi: 10.1073/pnas.87.21.8496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Radeke M. J., Misko T. P., Hsu C., Herzenberg L. A., Shooter E. M. Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature. 1987 Feb 12;325(6105):593–597. doi: 10.1038/325593a0. [DOI] [PubMed] [Google Scholar]
  44. Rodríguez-Tébar A., Dechant G., Götz R., Barde Y. A. Binding of neurotrophin-3 to its neuronal receptors and interactions with nerve growth factor and brain-derived neurotrophic factor. EMBO J. 1992 Mar;11(3):917–922. doi: 10.1002/j.1460-2075.1992.tb05130.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ruoslahti E., Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 1991 Mar 8;64(5):867–869. doi: 10.1016/0092-8674(91)90308-l. [DOI] [PubMed] [Google Scholar]
  46. Sano K., Nakamura H., Mabuchi S., Tanaka T., Nakagawara A., Takai Y. Expression of the smg p25A (a ras p21-like GTP-binding protein) gene in human neuroblastoma cell lines and tumor tissues. Cancer Res. 1990 Nov 15;50(22):7242–7245. [PubMed] [Google Scholar]
  47. Schlessinger J., Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron. 1992 Sep;9(3):383–391. doi: 10.1016/0896-6273(92)90177-f. [DOI] [PubMed] [Google Scholar]
  48. Schwab M., Alitalo K., Klempnauer K. H., Varmus H. E., Bishop J. M., Gilbert F., Brodeur G., Goldstein M., Trent J. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature. 1983 Sep 15;305(5931):245–248. doi: 10.1038/305245a0. [DOI] [PubMed] [Google Scholar]
  49. Seeger R. C., Brodeur G. M., Sather H., Dalton A., Siegel S. E., Wong K. Y., Hammond D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985 Oct 31;313(18):1111–1116. doi: 10.1056/NEJM198510313131802. [DOI] [PubMed] [Google Scholar]
  50. Seeger R. C., Siegel S. E., Sidell N. Neuroblastoma: clinical perspectives, monoclonal antibodies, and retinoic acid. Ann Intern Med. 1982 Dec;97(6):873–884. doi: 10.7326/0003-4819-97-6-873. [DOI] [PubMed] [Google Scholar]
  51. Sheng M., Greenberg M. E. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron. 1990 Apr;4(4):477–485. doi: 10.1016/0896-6273(90)90106-p. [DOI] [PubMed] [Google Scholar]
  52. Sonnenfeld K. H., Ishii D. N. Fast and slow nerve growth factor binding sites in human neuroblastoma and rat pheochromocytoma cell lines: relationship of sites to each other and to neurite formation. J Neurosci. 1985 Jul;5(7):1717–1728. doi: 10.1523/JNEUROSCI.05-07-01717.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Stein R., Orit S., Anderson D. J. The induction of a neural-specific gene, SCG10, by nerve growth factor in PC12 cells is transcriptional, protein synthesis dependent, and glucocorticoid inhibitable. Dev Biol. 1988 Jun;127(2):316–325. doi: 10.1016/0012-1606(88)90318-1. [DOI] [PubMed] [Google Scholar]
  54. Suzuki T., Bogenmann E., Shimada H., Stram D., Seeger R. C. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas. J Natl Cancer Inst. 1993 Mar 3;85(5):377–384. doi: 10.1093/jnci/85.5.377. [DOI] [PubMed] [Google Scholar]
  55. Tahira T., Ishizaka Y., Itoh F., Nakayasu M., Sugimura T., Nagao M. Expression of the ret proto-oncogene in human neuroblastoma cell lines and its increase during neuronal differentiation induced by retinoic acid. Oncogene. 1991 Dec;6(12):2333–2338. [PubMed] [Google Scholar]
  56. Takahashi K., Isobe T., Ohtsuki Y., Akagi T., Sonobe H., Okuyama T. Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in human neoplasm and normal tissues. Virchows Arch B Cell Pathol Incl Mol Pathol. 1984;45(4):385–396. doi: 10.1007/BF02889881. [DOI] [PubMed] [Google Scholar]
  57. Tapley P., Lamballe F., Barbacid M. K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. Oncogene. 1992 Feb;7(2):371–381. [PubMed] [Google Scholar]
  58. Torres M., Hall F. L., O'Neill K. Stimulation of human neutrophils with formyl-methionyl-leucyl-phenylalanine induces tyrosine phosphorylation and activation of two distinct mitogen-activated protein-kinases. J Immunol. 1993 Feb 15;150(4):1563–1577. [PubMed] [Google Scholar]
  59. Weskamp G., Reichardt L. F. Evidence that biological activity of NGF is mediated through a novel subclass of high affinity receptors. Neuron. 1991 Apr;6(4):649–663. doi: 10.1016/0896-6273(91)90067-a. [DOI] [PubMed] [Google Scholar]
  60. Yaeger M. J., Koestner A., Marushige K., Marushige Y. The use of nerve growth factor as a reverse transforming agent for the treatment of neurogenic tumors: in vivo results. Acta Neuropathol. 1992;83(6):624–629. doi: 10.1007/BF00299412. [DOI] [PubMed] [Google Scholar]

Articles from Molecular and Cellular Biology are provided here courtesy of Taylor & Francis

RESOURCES